Cargando…

Effects of sodium-glucose cotransporter 2 inhibitors on urinary excretion of intact and total angiotensinogen in patients with type 2 diabetes

We conducted a descriptive case study to examine the effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors on urinary angiotensinogen excretion, which represents the function of the intrarenal renin–angiotensin system, in patients with type 2 diabetes. An SGLT2 inhibitor (canagliflozin 100 mg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshimoto, Takuo, Furuki, Takayuki, Kobori, Hiroyuki, Miyakawa, Masaaki, Imachi, Hitomi, Murao, Koji, Nishiyama, Akira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Journal of Investigative Medicine 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812257/ https://www.ncbi.nlm.nih.gov/pubmed/28596160 http://dx.doi.org/10.1136/jim-2017-000445

Ejemplares similares

Polypharmacy influences the renal composite outcome in patients treated with sodium‐glucose cotransporter 2 inhibitors
por: Kobayashi, Kazuo, et al.
Publicado: (2022)

Angiotensin II Type 1 Receptor Blockers Reduce Urinary Angiotensinogen Excretion and the Levels of Urinary Markers of Oxidative Stress and Inflammation in Patients with Type 2 Diabetic Nephropathy
por: Ogawa, Susumu, et al.
Publicado: (2009)

Urinary Angiotensinogen Could Be a Prognostic Marker of Renoprotective Effects of Alogliptin in Patients with Type 2 Diabetes
por: Mizushige, Tomoko, et al.
Publicado: (2015)

Urinary excretion of renin and angiotensinogen in hypertensive children and adolescents
por: Zając, Magdalena, et al.
Publicado: (2019)

Urinary Angiotensinogen Could Be a Prognostic Marker of the Renoprotection of Olmesartan in Metabolic Syndrome Patients
por: Mizushige, Tomoko, et al.
Publicado: (2016)

Decreased expression of platelet human scavenger receptor class B type I in patients with type 2 diabetes mellitus
por: Imachi, Hitomi, et al.
Publicado: (2014)

The Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Sympathetic Nervous Activity
por: Wan, Ningning, et al.
Publicado: (2018)

Sodium–glucose cotransporter 2 inhibitor‐induced reduction in the mean arterial pressure improved renal composite outcomes in type 2 diabetes mellitus patients with chronic kidney disease: A propensity score‐matched model analysis in Japan
por: Kobayashi, Kazuo, et al.
Publicado: (2021)

Elevated urinary angiotensinogen excretion links central and renal hemodynamic alterations
por: Kosaki, Keisei, et al.
Publicado: (2023)

Circadian rhythm of plasma and urinary angiotensinogen in healthy volunteers and in patients with chronic kidney disease
por: Nishijima, Yoko, et al.
Publicado: (2014)

Transient Exposure of Enalapril Normalizes Prenatal Programming of Hypertension and Urinary Angiotensinogen Excretion
por: Mansuri, Asifhusen, et al.
Publicado: (2015)

A Lower Baseline Urinary Glucose Excretion Predicts a Better Response to the Sodium Glucose Cotransporter 2 Inhibitor
por: Hwang, You-Cheol, et al.
Publicado: (2019)

Baseline Urinary Angiotensinogen Excretion Predicts Deterioration of the Kidney Function in Patients with Chronic Kidney Disease
por: Ishigaki, Sayaka, et al.
Publicado: (2021)

Effect of renal denervation on urine angiotensinogen excretion in prenatally programmed rats
por: Mansuri, Asifhusen, et al.
Publicado: (2017)

Oxidative Stress/Angiotensinogen/Renin-Angiotensin System Axis in Patients with Diabetic Nephropathy
por: Kamiyama, Masumi, et al.
Publicado: (2013)

Transcriptional double-autorepression feedforward circuits act for multicellularity and nervous system development
por: Iwama, Hisakazu, et al.
Publicado: (2011)

Urinary angiotensinogen and urinary sodium are associated with blood pressure in normoalbuminuric children with diabetes
por: Soltysiak, Jolanta, et al.
Publicado: (2014)

Combination therapy of ipilimumab and nivolumab induced thyroid storm in a patient with Hashimoto’s disease and diabetes mellitus: a case report
por: Yonezaki, Kazuko, et al.
Publicado: (2018)

Co-existing of Neuromyelitis Optica and Fulminant Type 1 Diabetes
por: Saheki, Takanobu, et al.
Publicado: (2019)

Renal Expression and Urinary Excretion of Na-K-2Cl Cotransporter in Obstructive Nephropathy
por: Brandoni, Anabel, et al.
Publicado: (2017)

Comparison of the blood pressure management between sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists
por: Kobayashi, Kazuo, et al.
Publicado: (2022)

Relation between Blood Pressure Management and Renal Effects of Sodium-Glucose Cotransporter 2 Inhibitors in Diabetic Patients with Chronic Kidney Disease
por: Kobayashi, Kazuo, et al.
Publicado: (2019)

Insulin enhances renal glucose excretion: relation to insulin sensitivity and sodium-glucose cotransport
por: Ferrannini, Ele, et al.
Publicado: (2020)

Association between urinary angiotensinogen levels and renal and cardiovascular prognoses in patients with type 2 diabetes mellitus
por: Sawaguchi, Makoto, et al.
Publicado: (2012)

In Reply to “Letter Regarding ‘Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Urolithiasis’”
por: Anan, Go, et al.
Publicado: (2023)

The Urinary Glucose Excretion by Sodium–Glucose Cotransporter 2 Inhibitor in Patients With Different Levels of Renal Function: A Systematic Review and Meta-Analysis
por: Hu, Suiyuan, et al.
Publicado: (2022)

Human MicroRNAs Originated from Two Periods at Accelerated Rates in Mammalian Evolution
por: Iwama, Hisakazu, et al.
Publicado: (2013)

Human microRNAs preferentially target genes with intermediate levels of expression and its formation by mammalian evolution
por: Iwama, Hisakazu, et al.
Publicado: (2018)

Blood pressure after treatment with sodium–glucose cotransporter 2 inhibitors influences renal composite outcome: Analysis using propensity score‐matched models
por: Kobayashi, Kazuo, et al.
Publicado: (2020)

Diuretic Effects of Sodium Glucose Cotransporter 2 Inhibitors and Their Influence on the Renin-Angiotensin System
por: Ansary, Tuba M., et al.
Publicado: (2019)

High glucose augments angiotensinogen in human renal proximal tubular cells through hepatocyte nuclear factor-5
por: Wang, Juan, et al.
Publicado: (2017)

The effect of sodium/glucose cotransporter 2 (SGLT2) inhibition on the urinary proteome
por: Cherney, David, et al.
Publicado: (2017)

Thyroid stimulating hormone stimulates the expression of glucose transporter 2 via its receptor in pancreatic β cell line, INS-1 cells
por: Lyu, Jingya, et al.
Publicado: (2018)

Effects of 2-Methoxyestradiol, a Main Metabolite of Estradiol on Hepatic ABCA1 Expression in HepG2 Cells
por: Ibata, Tomohiro, et al.
Publicado: (2022)

Urinary Angiotensinogen Is Elevated in Patients with Nephrolithiasis
por: Sun, Wei, et al.
Publicado: (2014)

Glomerular angiotensinogen protein is enhanced in pediatric IgA nephropathy
por: Takamatsu, Masanori, et al.
Publicado: (2008)

Failure to confirm a sodium–glucose cotransporter 2 inhibitor‐induced hematopoietic effect in non‐diabetic rats with renal anemia
por: Yamazaki, Daisuke, et al.
Publicado: (2020)

Intrarenal Oxidative Stress and Augmented Angiotensinogen are Precedent to Renal Injury in Zucker Diabetic Fatty Rats
por: Suzaki, Yuki, et al.
Publicado: (2006)

Responses of renal hemodynamics and tubular functions to acute sodium–glucose cotransporter 2 inhibitor administration in non-diabetic anesthetized rats
por: Ansary, Tuba M., et al.
Publicado: (2017)

Detailed Localization of Augmented Angiotensinogen mRNA and Protein in Proximal Tubule Segments of Diabetic Kidneys in Rats and Humans
por: Kamiyama, Masumi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_khu73k3d6qntnt1lkvbtva9mju